NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
|||
| BNC941524-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Iga Antibody Laboratories manufactures the gliadin antibody iga neuroendocrine tumor reagents distributed by Genprice. The Gliadin Antibody Iga Neuroendocrine Tumor reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact iga antibody. Other Gliadin products are available in stock. Specificity: Gliadin Category: Antibody Group: Iga Neuroendocrine
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF405M conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF405M conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF405S conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF405S conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF640R conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF640R conjugate, Concentration: 0.1mg/mL |
||
NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody |
||
| Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
||
Iga Neuroendocrine information
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNCH2552-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNCB2552-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Biotin conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNCB2552-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Biotin conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNUB2552-100 | Biotium | 100uL | EUR 316.8 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Concentration: 0.2mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNUB2552-50 | Biotium | 50uL | EUR 486 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNUB2552-500 | Biotium | 500uL | EUR 615.6 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Concentration: 0.2mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC472552-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF647 conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC472552-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF647 conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC552552-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF555 conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC552552-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF555 conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC612552-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF660R conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC612552-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF660R conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC432552-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF543 conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC432552-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF543 conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC682552-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF568 conjugate, Concentration: 0.1mg/mL |
|||
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|||
| BNC682552-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Multiple organs neuroendocrine tumor tissue array with normal tissue |
|||
| NE841 | TissueArray | each | EUR 354 |
|
Description: Multiple organs neuroendocrine tumor tissue array with normal tissue |
|||